CASE STUDIES

Proven Across Real Trials

Accelerating HPV Therapeutic Development: Jeeva’s Role in FVT’s Phase II Clinical Trials

Explore how Frantz Viral Therapeutics uses Jeeva’s electronic data capture (EDC) platform to support ongoing Phase II trials for HPV-related precancerous conditions, including anal (AIN), vulvar (VIN), and cervical (CIN) intraepithelial neoplasia, with a focus on efficient clinical data management and regulatory requirements.

Accelerating HPV Therapeutic Development: Jeeva’s Role in FVT’s Phase II Clinical Trials

Explore how Frantz Viral Therapeutics uses Jeeva’s electronic data capture (EDC) platform to support ongoing Phase II trials for HPV-related precancerous conditions, including anal (AIN), vulvar (VIN), and cervical (CIN) intraepithelial neoplasia, with a focus on efficient clinical data management and regulatory requirements.

MetaClipse Therapeutics — Supporting an Industry-Sponsored Academic Medical Center Trial with Jeeva

Discover how Jeeva supports Metaclipse Therapeutics' early-phase oncology research at MD Anderson Cancer Center through remote follow-up, electronic patient-reported outcomes, and coordinated clinical trial workflows while maintaining essential safety oversight.

Metaclipse
MetaClipse Therapeutics — Supporting an Industry-Sponsored Academic Medical Center Trial with Jeeva

Discover how Jeeva supports Metaclipse Therapeutics' early-phase oncology research at MD Anderson Cancer Center through remote follow-up, electronic patient-reported outcomes, and coordinated clinical trial workflows while maintaining essential safety oversight.

Metaclipse
POLG Foundation — Enabling Global Rare Disease Research: Jeeva's Role in Multinational Natural History Studies

Discover how Jeeva supports the POLG Foundation's 14-country natural history study, helping address the complexities of global study coordination, regulatory requirements, and longitudinal data collection for POLG-related mitochondrial diseases.

POLG Foundation — Enabling Global Rare Disease Research: Jeeva's Role in Multinational Natural History Studies

Discover how Jeeva supports the POLG Foundation's 14-country natural history study, helping address the complexities of global study coordination, regulatory requirements, and longitudinal data collection for POLG-related mitochondrial diseases.

Paternal Registry and Multichannel Engagement for Special Fathers Network (SFN)

Discover how the Special Fathers Network (SFN), established by the 21st Century Dads Foundation, used Jeeva eClinical Cloud to support paternal registry research and gather insights into the challenges faced by fathers raising children with special needs.

Paternal Registry and Multichannel Engagement for Special Fathers Network (SFN) Powered by Jeeva
Paternal Registry and Multichannel Engagement for Special Fathers Network (SFN)

Discover how the Special Fathers Network (SFN), established by the 21st Century Dads Foundation, used Jeeva eClinical Cloud to support paternal registry research and gather insights into the challenges faced by fathers raising children with special needs.

Paternal Registry and Multichannel Engagement for Special Fathers Network (SFN) Powered by Jeeva
Clinical Stage Dermatology Sponsor

A Clinical Stage Dermatology Sponsor Enterprise license for decentralized dermatology trials for microbiome-based innovative products for deodorants, eczema, and other indications Relevant Jeeva™ eClinical Software

Dermatologist Checking Patient
Clinical Stage Dermatology Sponsor

A Clinical Stage Dermatology Sponsor Enterprise license for decentralized dermatology trials for microbiome-based innovative products for deodorants, eczema, and other indications Relevant Jeeva™ eClinical Software

Dermatologist Checking Patient
Clinical Stage Cancer-prevention Sponsor

From a single Phase II trial to an Enterprise license supporting three Phase II trials for Cancer prevention with innovative suppository products

Clinical Stage Cancer-prevention Sponsor
Clinical Stage Cancer-prevention Sponsor

From a single Phase II trial to an Enterprise license supporting three Phase II trials for Cancer prevention with innovative suppository products

Clinical Stage Cancer-prevention Sponsor
Connect rare disease patients of Indian diaspora everywhere with information, resources, experts, diagnostics, treatment options, and clinical trials.

Connect rare disease patients of Indian diaspora everywhere with information, resources, experts, diagnostics, treatment options, and clinical trials. Customer: IndoUSrare Indo US Organization for Rare Disease

woman in teal scrub suit sitting beside man in white medical scrub suit
Connect rare disease patients of Indian diaspora everywhere with information, resources, experts, diagnostics, treatment options, and clinical trials.

Connect rare disease patients of Indian diaspora everywhere with information, resources, experts, diagnostics, treatment options, and clinical trials. Customer: IndoUSrare Indo US Organization for Rare Disease

woman in teal scrub suit sitting beside man in white medical scrub suit
Health outcomes and biomarkers data collection for persons with neurodevelopmental disorders to accelerate treatment options

Health outcomes and biomarkers data collection for persons with neurodevelopmental disorders to accelerate treatment options Customer

a hand holding a small bottle of nail polish
Health outcomes and biomarkers data collection for persons with neurodevelopmental disorders to accelerate treatment options

Health outcomes and biomarkers data collection for persons with neurodevelopmental disorders to accelerate treatment options Customer

a hand holding a small bottle of nail polish
Patient registry for muscular dystrophies to accelerate #Genetherapy development

Patient registry for muscular dystrophies to accelerate #Genetherapy development Customer: Cure Rare Disease curerd.org is on a mission to research and develop cost-effective, lifesaving long-term therapies

woman in red and white dress
Patient registry for muscular dystrophies to accelerate #Genetherapy development

Patient registry for muscular dystrophies to accelerate #Genetherapy development Customer: Cure Rare Disease curerd.org is on a mission to research and develop cost-effective, lifesaving long-term therapies

woman in red and white dress
Remote Video eConsent for a Biospecimen Collection Study with Pediatric and Maternal Patients

Remote Video eConsent for a Biospecimen Collection Study with Pediatric and Maternal Patients Customer: Childrens National Hospital #5 childrens hospital in the United States

a woman is giving a boy a high five
Remote Video eConsent for a Biospecimen Collection Study with Pediatric and Maternal Patients

Remote Video eConsent for a Biospecimen Collection Study with Pediatric and Maternal Patients Customer: Childrens National Hospital #5 childrens hospital in the United States

a woman is giving a boy a high five
Revolutionizing Interventional Radiology: How Jeeva and IR Centers USA are Transforming Patient Outcomes

Revolutionizing Interventional Radiology: How Jeeva and IR Centers USA are Transforming Patient Outcomes IR Centers IR Centers™️ leads Interventional Radiology, offering cutting-edge, minimally invasive treatments

a few men looking at a computer screen
Revolutionizing Interventional Radiology: How Jeeva and IR Centers USA are Transforming Patient Outcomes

Revolutionizing Interventional Radiology: How Jeeva and IR Centers USA are Transforming Patient Outcomes IR Centers IR Centers™️ leads Interventional Radiology, offering cutting-edge, minimally invasive treatments

a few men looking at a computer screen
See how a five year cohort study with 2,500 participants transitioned to Jeeva eClinical Cloud to support remote follow up, data collection, and study management.

A 5-yr longitudinal cohort study with 2500 participants transitions to the Jeeva™ eClinical Cloud platform The study team operates at a top nationally-ranked researching university

A 5-yr longitudinal cohort study with 2500 participants transitions to the Jeeva™ eClinical Cloud platform
See how a five year cohort study with 2,500 participants transitioned to Jeeva eClinical Cloud to support remote follow up, data collection, and study management.

A 5-yr longitudinal cohort study with 2500 participants transitions to the Jeeva™ eClinical Cloud platform The study team operates at a top nationally-ranked researching university

A 5-yr longitudinal cohort study with 2500 participants transitions to the Jeeva™ eClinical Cloud platform
Partnering for Success: the Pioneers of Affordable CAR-T Cell/Gene Therapy for Leukemias and Lymphomas.

ImmunoACT is pioneering the first affordable cell and gene therapies in India for patients’ long-term cures through translational research and beyond. CAR-T cell therapies are highly effective in curing certain type of Cancers Leukemia and Lymphoma.

a double strand of blue and white spirals
Partnering for Success: the Pioneers of Affordable CAR-T Cell/Gene Therapy for Leukemias and Lymphomas.

ImmunoACT is pioneering the first affordable cell and gene therapies in India for patients’ long-term cures through translational research and beyond. CAR-T cell therapies are highly effective in curing certain type of Cancers Leukemia and Lymphoma.

a double strand of blue and white spirals